Virtu Financial’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-28,917
Closed -$616K – 2066
2024
Q1
$616K Buy
+28,917
New +$346K 0.05% 352
2023
Q2
– Sell
-13,084
Closed -$49K – 2228
2023
Q1
$49K Buy
+13,084
New +$51.5K 0.01% 1102

Virtu Financial's FUSN Position: Q2 2024 in Review

Virtu Financial sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 28,917 shares — an estimated $616K sold.

Virtu Financial first reported a position in FUSN in Q1 2023 and held it in 2 quarters. The position peaked at $616K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

  • Virtu Financial reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
  • Virtu Financial sold 28,917 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $616K.
  • Virtu Financial first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2023 and held it in 2 quarters.
  • Virtu Financial's Fusion Pharmaceuticals Inc. Common Shares position peaked at $616K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.